Trial Outcomes & Findings for Effect of Post-operative Ibuprofen After Surgery for Chronic Rhinosinusitis (NCT NCT03055507)

NCT ID: NCT03055507

Last Updated: 2023-03-22

Results Overview

10-cm visual analogue scale used to indicate level of post-operative pain. 0 indicates no pain and 10 indicates worst pain imaginable.

Recruitment status

COMPLETED

Study phase

PHASE2/PHASE3

Target enrollment

42 participants

Primary outcome timeframe

Post-operative day 1

Results posted on

2023-03-22

Participant Flow

Participant milestones

Participant milestones
Measure
Control
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Overall Study
STARTED
16
26
Overall Study
COMPLETED
16
26
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=16 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=26 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Total
n=42 Participants
Total of all reporting groups
Age, Continuous
45 years
STANDARD_DEVIATION 16 • n=16 Participants
53 years
STANDARD_DEVIATION 18.5 • n=26 Participants
49 years
STANDARD_DEVIATION 17 • n=42 Participants
Sex: Female, Male
Female
8 Participants
n=16 Participants
14 Participants
n=26 Participants
22 Participants
n=42 Participants
Sex: Female, Male
Male
8 Participants
n=16 Participants
12 Participants
n=26 Participants
20 Participants
n=42 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
16 participants
n=16 Participants
26 participants
n=26 Participants
42 participants
n=42 Participants
Chronic rhinonsinusitis (CRS) with Nasal Polyposis
1 Participants
n=16 Participants
12 Participants
n=26 Participants
13 Participants
n=42 Participants
Duration of surgery
90 minutes
STANDARD_DEVIATION 44.2 • n=16 Participants
91 minutes
STANDARD_DEVIATION 49.1 • n=26 Participants
90 minutes
STANDARD_DEVIATION 46 • n=42 Participants
Estimated blood loss
49 milliliters
STANDARD_DEVIATION 34.7 • n=16 Participants
51 milliliters
STANDARD_DEVIATION 22.6 • n=26 Participants
51 milliliters
STANDARD_DEVIATION 30 • n=42 Participants
Lund-MacKay CT grading Score
9.4 units on a scale
STANDARD_DEVIATION 6 • n=16 Participants
10.1 units on a scale
STANDARD_DEVIATION 6 • n=26 Participants
9.8 units on a scale
STANDARD_DEVIATION 6 • n=42 Participants
Sinonasal outcome test-22 score (SNOT-22)
44 units on a scale
STANDARD_DEVIATION 22.6 • n=16 Participants
42 units on a scale
STANDARD_DEVIATION 18.9 • n=26 Participants
42 units on a scale
STANDARD_DEVIATION 19.7 • n=42 Participants
Number of sinuses operated
5.3 sinuses
STANDARD_DEVIATION 2.4 • n=16 Participants
5.9 sinuses
STANDARD_DEVIATION 1.8 • n=26 Participants
5.7 sinuses
STANDARD_DEVIATION 2.1 • n=42 Participants

PRIMARY outcome

Timeframe: Post-operative day 1

10-cm visual analogue scale used to indicate level of post-operative pain. 0 indicates no pain and 10 indicates worst pain imaginable.

Outcome measures

Outcome measures
Measure
Control
n=16 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=26 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Pain Visual Analogue Scale (VAS)
3.3 units on a scale
Standard Deviation 2.1
2.3 units on a scale
Standard Deviation 2.1

PRIMARY outcome

Timeframe: Post-operative day 3

Population: Patients undergoing sinus surgery stratified into study arms

10-cm visual analogue scale used to indicate level of post-operative pain. 10-cm visual analogue scale used to indicate level of post-operative pain. 0 indicates no pain and 10 indicates worst pain imaginable.

Outcome measures

Outcome measures
Measure
Control
n=16 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=26 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Pain Visual Analogue Scale
3.0 units on a scale
Standard Deviation 2.1
1.7 units on a scale
Standard Deviation 1.4

PRIMARY outcome

Timeframe: Post-operative day 7

Population: Same as previous

10-cm visual analogue scale used to indicate level of post-operative pain. Scale from 0-10 with 0 indicating no pain and 10 indicating worst pain imaginable.

Outcome measures

Outcome measures
Measure
Control
n=16 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=26 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Pain Visual Analogue Scale
3.3 units on the pain visual analogue scale
Standard Deviation 2.1
2.3 units on the pain visual analogue scale
Standard Deviation 2.1

SECONDARY outcome

Timeframe: Post-operative days 1-7

Number of opioid pills taken daily following surgery

Outcome measures

Outcome measures
Measure
Control
n=16 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=24 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Number of Opioid Pills
4 pills per day
Standard Deviation 1
4 pills per day
Standard Deviation 1

SECONDARY outcome

Timeframe: Post-operative days 1, 3, and 7

10-cm visual analogue scale used to indicate amount of nasal bleeding post-operatively. 0 = no bleeding, 10 = life-threatening bleeding

Outcome measures

Outcome measures
Measure
Control
n=15 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=24 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Bleeding Visual Analogue Scale
Post-operative day 1
3.2 units on a scale
Standard Deviation 2.0
2.3 units on a scale
Standard Deviation 2.1
Bleeding Visual Analogue Scale
Post-operative day 3
3.2 units on a scale
Standard Deviation 2.1
2.3 units on a scale
Standard Deviation 1.8
Bleeding Visual Analogue Scale
Post-operative day 7
1.2 units on a scale
Standard Deviation 0.6
0.5 units on a scale
Standard Deviation 1.1

SECONDARY outcome

Timeframe: Post-operative days 1, 3, and 7

Previously used 0-4 scale to indicate amount of nasal bleeding. 0 indicating no bleeding and 4 indicating life threatening bleeding.

Outcome measures

Outcome measures
Measure
Control
n=15 Participants
Standard pain regimen of acetaminophen 650 mg q6hrs while awake until cessation of need for scheduled pain medication with the addition of oxycodone 5 mg q3 hrs PRN pain. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
Ibuprofen
n=24 Participants
Alternating every 3 hours acetaminophen 650 mg and ibuprofen 400 mg while awake until cessation of need for schedule pain medication with the addition of oxycodone 5 mg q3hr PRN pain. Ibuprofen 400 mg: Addition of ibuprofen to standard pain regimen. Acetaminophen 650 mg: Standard analgesic provided post-operatively to patients undergoing sinus surgery OxyCODONE 5 Mg Oral Tablet: Standard PRN medication offered post-operatively for breakthrough pain
0-4 Bleeding Scale
Post-operative day 1
1.5 score on a scale
Standard Deviation 1.0
0.9 score on a scale
Standard Deviation 0.6
0-4 Bleeding Scale
Post-operative day 3
1.5 score on a scale
Standard Deviation 1.0
0.9 score on a scale
Standard Deviation 0.6
0-4 Bleeding Scale
Post-operative day 7
0.7 score on a scale
Standard Deviation 0.6
0.3 score on a scale
Standard Deviation 0.5

POST_HOC outcome

Timeframe: Post operative days 1, 3 & 7

Population: No participants were analyzed

Number of changes to post-operative wound dressing. This outcome was not collected based on difficulty with patient compliance. No data was gathered on this outcome measure.

Outcome measures

Outcome data not reported

Adverse Events

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Ibuprofen

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Greg Davis, Director of Rhinology and Skull Base

University of Washington, Department of Otolaryngology - Head & Neck Surgery

Phone: (206) 598-4022

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place